-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Alkermes, Raises Price Target to $61

Benzinga·07/29/2026 18:08:37
Listen to the news
JP Morgan analyst Jessica Fye maintains Alkermes (NASDAQ:ALKS) with a Neutral and raises the price target from $60 to $61.